Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, making it valuable in drug discovery programs focused on oncology. It is also employed in the preparation of bioactive molecules with antiviral and anti-inflammatory properties. Due to its halogenated heterocyclic framework, it serves as a building block in medicinal chemistry for structure-activity relationship (SAR) studies and scaffold optimization.